In this video we will discuss Ivermectin for COVID-19. We have been covering studies on Ivermectin since April 4th. Since then, we have put together a comprehensive list of the current literature that has explored the efficacy of Ivermectin to treat and prevent COVID-19. Given the growing number of beneficial studies, we decided it was time to put together a video that summarizes all of these studies to date. We will discuss the 9 current studies available that vary from outpatient treatment to inpatient treatment of both moderate and/or severe COVID-19. Some studies look at Ivermectin solo therapy and others use combination therapy including doxycycline, hydroxychloroquine, azithromycin, vitamin D, aspirin, dexamethasone, enoxaparin, and more! We hope this video serves as a resource for you all to understand and share where we are currently with evidence on the efficacy of Ivermectin and it’s utility to treat COVDI-19 in various stages. Check out the video for all the details.
DO NOT MISS VIDEO!
Interview with Dr. Hector Carvallo, pioneer in Ivermectin therapy for COVID-19 and lead investigator on the IDEA and IVERCAR Trials:
UNDERSTAND HOW IVERMECTIN MAY WORK IN PREVENTING AND TREATING COVID-19:
Four Different Mechanisms of Action Of IVM:
SUMMARY OF EVIDENCE ON IVERMECTIN TO PREVENT COVID-19:
IVM Prophylaxis: Summary of Evidence to Date:
Additional videos on IVM and COVID-19:
IVM Nasal Spray for COVID-19:
IVM, Nitazoxanide, Hydroxychloroquine and COVID-19:
Ivermectin, Azithromycin, And Vitamin D Early Outpatient COVID-19:
Ivermectin And The STAT3 Pathway: A New Mechanism Of Action:
Randomized, Double Blinded Placebo Controlled Trial IVM+Doxycycline:
IDEA Trial (Ivermectin, Dexamethasone, Enoxaparin, Aspirin) Mild, Mod, Sever COVID:
Ivermectin to Treat Hospitalized Patients with COVID-19:
IVERCAR (Ivermectin and Carrageenan Prophylaxis):
Ivermectin Inhibits RNA Dependent RNA Polymerase
Ivermectin Post-Exposure Prophylaxis:
Ivermectin Prophylaxis For COVID-19:
Ivermectin and Doxycycline To Treat Mild to Moderate COVID-19:
Ivermectin, Hydroxychloroquine, and Azithromycin for Hospitalized COVID-19 patients:
Ivermectin and new mechanism; halting thrombi through inhibition of CD147:
ICON Trial:
Clinical Trial on Ivermectin (data may be falsified):
In Vitro on Ivermectin for COVID-19, 99.99% Decrease in Viral Load:
Ivermectin+Doxycyline Compared to Hydroxychloroquine+Azithromycin for COVID-19:
If you enjoy the content and feel inclined, here are some ways in which you can support us! Funds will go towards purchasing better equipment/software, dedicating more time to the channel, and continuing to strive towards taking this channel to the next level!
Buy Us A Coffee:
A cool site where you can donate a few dollars to a Creator of your choosing as a tip!
YouTube Membership
There will be a running series of videos using the most up to date information on COVID-19. Stick with us as we work to unveil the intricacies of COVID-19, it’s clinical significance, and the societal implications. ***This is strictly educational and not to be mistaken as clinical recommendations, please verify all information with accepted guidelines and practice patterns.***
DISCLAIMER
THIS VIDEO DOES NOT PROVIDE MEDICAL ADVICE. The information, including but not limited to, text, graphics, images and other material contained on this website are for informational purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read, watched, or listened to on this video, or any other videos, reports, texts tweets or other sources.
